Sissoko, M. S., Healy, S. A., Katile, A., Zaidi, I., Hu, Z., Kamate, B., Samake, Y., Sissoko, K., Mwakingwe-Omari, A., Lane, J., Imeru, A., Mohan, R., Thera, I., Guindo, C. O., Dolo, A., Niare, K., Koïta, F., Niangaly, A., Rausch, K. M., Zeguime, A., Guindo, M. A., Bah, A., Abebe, Y., James, E. R., Manoj, A., Murshedkar, T., KC, N., Sim, B. K. L., Billingsley, P. F., Richie, T. L., Hoffman, S. L., Doumbo, O., & Duffy, P. E. (2022). safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial. Lancet infectious diseases, 22(3), 377–389. http://access.bl.uk/ark:/81055/vdc_100152303113.0x000015